Tinnitus Management Market is projected to grow at a CAGR of 3.7%, reaching an impressive USD 3.7 billion by 2033.

Takeda, Vabiotech - Market Forecast to 2030 GlobeNewswire (Press Release) 16:11 Wed, 28 Aug Over the Counter (OTC) Drugs Market Report 2024-2030: Features Strategic Company Profiles of 42 Players ...

Takeda (NYSE: TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved ADZYNMA (ADAMTS13, recombinant-krhn) for the prophylactic and on-demand treatment... Takeda (NYSE: TAK) ...

It looks like the biggest pharma merger of the year so far is on, after Shire recommended shareholders accept a bid from Takeda worth around £46 billion. After a series of bids from the Japanese ...

Stoke Therapeutics, Inc. (Nasdaq: STOK), a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine, today announced the appointment of Eric ...

Environmental DNA samples taken from ocean beaches and estuaries in Sutherland Shire have revealed many "hidden" species of sealife.

A new appointee with more than two decades of comms experience will soon take the reins of Takeda’s worldwide brand strategy. The Big Pharma has selected Anne de Schweinitz to serve as head of ...

In this article, we are going to take a look at where Takeda Pharmaceutical Company Limited (NYSE:TAK) stands against the other cheap pharmaceutical stocks. The pharmaceutical industry is one of ...

Please verify your email address. Tales of the Shire immerses players into Hobbit life, offering cooking, feasting, and ale-drinking experiences in a cozy setting. The game's success hinges on ...

TAK-500 is under clinical development by Takeda Pharmaceutical and currently in Phase II for Non-Small Cell Lung Cancer. According to GlobalData, Phase II drugs for Non-Small Cell Lung Cancer have a ...